RxDoctor Payments Data

Jennifer Adkins, APRN

Family · Baxter Springs, KSNPI 1942550579

Payments from drug & device makers

$398in general payments, 2019–2025

Across 22 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$142
  • Axsome Therapeutics, Inc.$76
  • Alkermes, Inc.$49
  • Astellas Pharma US Inc$29
  • Pfizer$23
  • Vanda Pharmaceuticals Inc.$22
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$398100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$398 in reported general payments places this provider in the 55th percentile of 1,579 family providers in Kansas.

See all family providers in Kansas

Medicare billing

Part B allowed, 2024
$5,341
Medicare patients
103
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide144$196,995
FarxigaDapagliflozin Propanediol86$126,617
MounjaroTirzepatide62$80,941
JardianceEmpagliflozin48$74,059
OzempicSemaglutide46$69,774
Trelegy ElliptaFluticasone/Umeclidin/Vilanter57$61,666
EliquisApixaban43$53,303
RexultiBrexpiprazole27$50,736
VraylarCariprazine Hcl32$45,661
MyrbetriqMirabegron36$31,336
JanuviaSitagliptin Phosphate15$24,221
TradjentaLinagliptin17$23,409
Spiriva RespimatTiotropium Bromide28$16,902
SymbicortBudesonide/Formoterol Fumarate43$16,669
LinzessLinaclotide15$16,239

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$142$277,937206 claims
AstraZenecaFarxiga, Symbicort$13$143,286129 claims
AbbVieVraylar, Linzess$15$61,90047 claims
PfizerEliquis$23$53,30343 claims
Astellas Pharma US IncMyrbetriq$29$31,33636 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,579 family providers in Kansas.

Other family in Baxter Springs

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →